3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, CB; Brunt, EM; Mangino, MJ; Von Doersten, P | 1 |
| Bitterman, H; Lefer, AM; Lefer, DJ | 1 |
2 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and Acute Disease
| Article | Year |
|---|---|
Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
Topics: Acute Disease; Animals; Dogs; Glomerular Filtration Rate; Graft Rejection; Kidney Transplantation; Prostaglandins; Pyridines; Renal Circulation; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous | 1989 |
Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemia.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Coronary Disease; Creatine Kinase; Drug Therapy, Combination; Heart Rate; Male; Myocardial Infarction; Myocardium; Pyridines; Rats; Rats, Inbred Strains; Thromboxane-A Synthase; Vasoconstriction | 1987 |